# Autonomous OPEN Agentic Swing Scan — 2026-08-17

- Timestamp: 2026-08-17 13:36–13:38 UTC / 09:36–09:38 ET
- Account: Robinhood Agentic ••••1041 only
- Policy: `playbook/autonomous-policy.md` ACTIVE; no date-specific 2026-08-17 plan found
- Mode: pre-authorized equity execution
- Decision: EXIT AVGO after confirmed thesis failure; HOLD MA/BAC/SHOP; no new opening entry during price discovery.

## Broker state and gates

- Account verified active cash account, `agentic_allowed=true`; no other account used.
- Pre-action value $334.01; equities $301.90; cash and authoritative buying power $32.11; unsettled funds $0.
- Kill switch clear: account value >$10. Approximate change from Aug. 15 snapshot $335.09 was -0.32%, below the 5% daily pause; recent snapshots do not indicate a 10% drawdown.
- Pre-action positions: AVGO 0.095750 @ $411.28; MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12; SHOP 0.862075 @ $144.09.
- All open-ish equity states checked separately before action: new, queued, confirmed, unconfirmed, partially_filled — empty.
- Recent fills since Aug. 10: NESR buy 0.736516 @ $33.7399 Aug. 10; NESR sell 0.736516 @ $35.1601 Aug. 12.
- Broker/account/quote state coherent; regular market live.

## Market regime

- Mixed/risk-on rotation at 09:36 ET. Prior closes: SPY $776.34 above SMA20 $756.20 / SMA50 $748.93; QQQ $731.07 above SMA20 $704.13 / SMA50 $712.95, though SMA20 remained below SMA50; IWM $305.09 above SMA20 $296.72 / SMA50 $295.10.
- Opening tape: SPY -0.08%, QQQ +0.28%, IWM -0.41%; XLK +0.53% led while XLF, XLE, XLI were near flat and defensive sectors lagged. This was not broad confirmation, so opening entries required retests rather than chase orders.
- Macro/event context: low VIX/complacency, persistent rate-hike uncertainty, weak July retail sales; housing/industrial data Tuesday, FOMC minutes Wednesday, and HD/TJX/TGT/LOW/WMT earnings this week. No major Monday data expected.

## Position decisions

Stops are scan-managed invalidations, not resting orders.

1. BAC — HOLD, 14/16. Live $64.735; value ~$67.74; +$2.74/+4.21%. Above SMA20 $62.61 / SMA50 $59.64, near $65.20 resistance; Q2 revenue $31.56B and net income $9.07B improved. Binding invalidation $61.40; targets $66/$68. No add at resistance.
2. SHOP — HOLD/protect winner, 12/16. Live $153.19; value ~$132.06; +$7.84/+6.32%. Above SMA20 $133.59 / SMA50 $122.91, 20-day momentum +24.66%, but extended and high valuation. Binding stop $143.50; targets $160/$166; no add.
3. MA — HOLD, 10/16. Live $566.88; value ~$64.36; -$0.64/-0.98%. Above SMA20 $559.40 / SMA50 $529.25; Q2 revenue $9.28B, net income $4.39B, margin 47.3%. Binding invalidation $550; targets $583.70/$596.
4. AVGO — EXITED, 8/16. Opening $395 area failed to reclaim the written $410 invalidation after Friday's high-volume breakdown. It remained below SMA20 $399.49 and had negative 60-day momentum. Strong revenue/margins did not override failed swing structure. No averaging down or stop widening.

## Broad scan and ranked candidates

Universe included Daily Movers and liquid mega-cap/sector leaders beyond stale watchlists.

1. NVDA — 12/16 WATCH. Prior close $225.16; SMA20 $210.39, SMA50 $206.52, 20-day momentum +11.02%, ATR14 $6.84. Strong revenue/margin trend and AI demand; earnings Aug. 26 creates event risk. Trigger only on $216–220 retest hold or confirmed breakout-retest above $227.50; stop $205; targets $236.50/$250. No opening chase.
2. AXTI — 11/16 REDUCED-SIZE WATCH. Live ~$87.32; prior close $82.03; SMA20 $62.27, SMA50 $69.20; 20-day +78.87% but 60-day -27.33%; ATR14 $11.50. Q2 revenue $47.59M and net margin 23.38% improved sharply, with AI optical-material demand/Lumentum agreement supporting the catalyst. Too volatile and extended for an opening entry; require consolidation/retest near $80–82, invalidation below ~$75, targets $90.40/$100.
3. ARGX — 10/16 GAP-HOLD WATCH. Live ~$967, +13.6%, new 52-week high; direct business/M&A/analyst context exists, but prior close was below SMA20/SMA50 and opening spread/extension were unsuitable. Require multi-hour or multi-session hold/retest around $925–935; invalidation below $900; targets $1,000/$1,050. No chase.
4. MESO — 8/16 NO TRADE. Live ~$16.99; SMA20 $15.54/SMA50 $15.11 but negative 20-day momentum, sub-500k average volume, loss-making biotech, and no verified fresh catalyst sufficient for entry.
5. AMZN/CAT — watch only. AMZN quality is strong but 20-day momentum only +6.24% and opening weak; CAT below SMA50 with ATR too wide for sandbox risk math.

## Order review and execution

- Reviewed: sell AVGO 0.095750 shares, market, regular hours, GFD.
- Broker checks: no alerts.
- Required quote disclosure: Bid $393.53 × 80 Q · Ask $393.65 × 80 Q · Last $393.53 × 50 Q. Updated 9:37 AM ET.
- Placed agentically under active policy; order ID `6a830ea7-840c-4031-926c-664a1e3077b8`.
- Filled: sell 0.095750 AVGO @ $393.5001 at 2026-08-17T13:37:43.664Z; fees $0.
- Proceeds: ~$37.68. Estimated realized loss versus broker average cost: -$1.70 (-4.32%).

## Post-action state / liquidity

- Post-action value $333.38; equities $263.59; cash $69.79.
- Authoritative settled buying power remains $32.11; AVGO proceeds $37.68 are unsettled and not spendable in this cash account.
- No open-ish orders after the fill; positions verified as MA, BAC, SHOP only.
- Available liquid buying power after pending orders: $32.11. Policy target deployable amount: $25.69 (80%); required settled-cash buffer: $6.42 (20%).
- Cash deployed into new positions this run: $0. The opening tape offered no confirmed 13+ retest and the operator avoided forced rotation/chasing. Existing equity exposure remains ~$263.59 / $333.38 = ~79.1%.

## Tool/data notes

- Date-specific 2026-08-17 trading plan was absent; live policy and prior Aug. 15 management notes governed.
- Historical payloads were persisted due size and parsed programmatically into compact SMA/ATR/momentum/volume fields.
- Financials returned no data for ARGX and MESO; this reduced conviction rather than being silently ignored.
